HuagongsheHuagongshe Chemistry Print Report · For research reference only
Sodium Iodide → 7-[2-(4-Cyclobutylpiperazin-1-yl)-2-oxoethyl]-3-chloro-5,6,7,8-tetrahydropyrido[3,4-c]pyridazine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Sodium Iodide | HCID 5238 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | 2-Chloro-(4-cyclobutyl-piperazine) acetamide | HCID 66877902 | — |
| Reactant | 3-chloro-5H,6H,7H,8H-pyrido(3,4-c)pyridazine hydrochloride | HCID 86346446 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | 7-[2-(4-Cyclobutylpiperazin-1-yl)-2-oxoethyl]-3-chloro-5,6,7,8-tetrahydropyrido[3,4-c]pyridazine | HCID 59463564 | — |
Reaction Steps
To a stirred solution of 3-chloro-5,6,7,8-tetrahydropyrido[3,4-c]pyridazine hydrogen chloride salt (0.9 g) in acetonitrile (10.0 ml) is added 2-chloro-(4-cyclobutyl-piperazine)-acetamide (1 g), K2CO3 (1.6 g), and NaI (50 mg). The resulting mixture is stirred at rt overnight. Water (20.0 ml) is added to quench the reaction, and then the acetonitrile is evaporated. The residue is extracted with DCM (20 ml×3). The combined organic phase is dried over sodium sulfate, and the solvent is removed under reduced pressure to give a residue which is purified by silica gel chromatography (EtOAc/4% TEA) to give the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07795262B2 |
| Source dataset | uspto-grants-2010_09 |
| ORD ID | ord-52de19e2aa23424ea75abb87c23142da |
| Source note | uspto-grants-2010_09 |